The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGSS.L Regulatory News (GSS)

  • There is currently no data for GSS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison issues review on Genesis Emerging Markets

9 May 2019 16:10

RNS Number : 5693Y
Genesis Emerging Markets Fund Ld
09 May 2019
 

 

London, UK, 9 May 2019

Edison issues review on Genesis Emerging Markets Fund (GSS)

Genesis Emerging Markets Fund (GSS) was launched in 1989 and was one of the first emerging markets funds to be listed in the UK. It aims to deliver long-term capital growth through investing in emerging and frontier markets. The investment approach is bottom-up and patient, involving proprietary and bespoke research to build in-depth knowledge of companies, sectors and countries. Unconstrained by benchmark considerations, the diversified portfolio is meaningfully differentiated from the index and consists of the manager's highest-conviction stocks.

 

GSS's current discount to cum-income NAV of 9.3% is narrower than its three-year average of 12.4%. The discount is a key focus for the board, which has committed to a tender offer for 25% of issued shares in June 2021 should the fund's performance lag the benchmark over the preceding five years.

Click here to view the full report.

 

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information please contact Edison:

Helena Coles, +44 (0)20 3681 2522

Gavin Wood, +44 (0)20 3681 2503

investmenttrusts@edisongroup.com

 

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-investment-research 

Twitter www.twitter.com/Edison_Inv_Res 

YouTube www.youtube.com/edisonitv 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRALLFIEETIAIIA
Date   Source Headline
20th May 202011:33 amRNSNet Asset Value(s)
19th May 202010:57 amRNSNet Asset Value(s)
18th May 202010:48 amRNSNet Asset Value(s)
15th May 202011:12 amRNSNet Asset Value(s)
14th May 20201:17 pmRNSAvailability of Monthly Factsheet
14th May 202010:29 amRNSNet Asset Value(s)
13th May 202012:21 pmRNSAppointment of Joint Corporate Broker
13th May 202010:36 amRNSNet Asset Value(s)
12th May 202010:37 amRNSNet Asset Value(s)
11th May 202010:27 amRNSNet Asset Value(s)
7th May 202010:52 amRNSNet Asset Value(s)
6th May 202010:54 amRNSNet Asset Value(s)
5th May 202011:04 amRNSNet Asset Value(s)
4th May 20201:32 pmRNSNet Asset Value(s)
4th May 202012:53 pmRNSNet Asset Value(s)
1st May 20202:28 pmRNSNet Asset Value(s)
30th Apr 20205:25 pmRNSTotal Voting Rights
30th Apr 202010:54 amRNSNet Asset Value(s)
29th Apr 202011:37 amRNSNet Asset Value(s)
28th Apr 202011:07 amRNSNet Asset Value(s)
27th Apr 20201:04 pmRNSDisclosure of rights attached to equity shares
27th Apr 202010:54 amRNSNet Asset Value(s)
24th Apr 202010:42 amRNSNet Asset Value(s)
23rd Apr 202010:57 amRNSNet Asset Value(s)
22nd Apr 202011:47 amRNSNet Asset Value(s)
21st Apr 202011:02 amRNSNet Asset Value(s)
20th Apr 202011:47 amRNSNet Asset Value(s)
17th Apr 202010:42 amRNSNet Asset Value(s)
16th Apr 202011:27 amRNSNet Asset Value(s)
15th Apr 202012:12 pmRNSNet Asset Value(s)
15th Apr 202010:28 amRNSAvailability of Monthly Factsheet
14th Apr 202011:17 amRNSNet Asset Value(s)
9th Apr 202010:47 amRNSNet Asset Value(s)
8th Apr 202012:03 pmRNSNet Asset Value(s)
7th Apr 202011:31 amRNSNet Asset Value(s)
6th Apr 202011:03 amRNSNet Asset Value(s)
3rd Apr 202011:33 amRNSNet Asset Value(s)
2nd Apr 202010:32 amRNSNet Asset Value(s)
1st Apr 20204:29 pmRNSEdison review on Genesis Emerging Markets Fund
1st Apr 20201:27 pmRNSNet Asset Value(s)
31st Mar 202011:52 amRNSNet Asset Value(s)
30th Mar 202012:18 pmRNSNet Asset Value(s)
27th Mar 202012:06 pmRNSNet Asset Value(s)
26th Mar 202011:32 amRNSNet Asset Value(s)
25th Mar 202011:31 amRNSNet Asset Value(s)
24th Mar 202012:42 pmRNSNet Asset Value(s)
23rd Mar 202012:08 pmRNSNet Asset Value(s)
20th Mar 202012:03 pmRNSNet Asset Value(s)
19th Mar 202011:07 amRNSNet Asset Value(s)
18th Mar 202011:52 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.